SDZXF:OTCMKTS
Sandoz Group AG
84,03 $
0,00%
(0,00) 1D
23 սեպ, 15:20:07 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZXF...
Mkt. cap
30,72 մլրդ
Avg. vol.
122,00
Volume
36,00
52-wk high
94,55 $
52-wk low
58,48 $
Shares outstanding
440,00 մլն
No. of employees
20 հզր
Mkt. cap
30,72 մլրդ
Avg. vol.
122,00
Volume
36,00
52-wk high
94,55 $
52-wk low
58,48 $
Shares outstanding
440,00 մլն
No. of employees
20 հզր
News stories
From web sources and news partners
Medical Daily
·
12 ժամ առաջ
Consumers Who Bought Certain Generics From 2009 to 2019 Can Claim Share of $400 Million Sandoz Settlement
KBND
·
3 օր առաջ
Drug Company Settlement
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG